论文部分内容阅读
近年来,脑膜炎双球菌对磺胺嘧啶的敏感性有所下降,且付作用较多,所以寻求一种疗效高、付作用少的防治药品,是防治流脑工作中需要解决的一个问题。据报导复方新诺明对流脑有较好的临床效果。为进一步观察该药的确实效果,我们于1978年2月至4月应用复方新诺明治疗流脑患者27例,初证步明复方新诺明治疗流脑有较好的临床效果。现报告如下:一、病例选择:诊断参照1975年《全国防治流脑经验交流学习班讨论试行稿》的诊断标准。凡确诊为流脑的患者,在病后确未用过或仅用过1～2次小剂量有效药物,对病情尚无影响者,给予复方新诺明治疗。
In recent years, meningococcal sensitivity to sulfadiazine decreased, and the pay more, so looking for a high efficacy, pay less for the prevention and treatment of drugs, prevention and treatment of meningitis is a problem to be solved. It has been reported that cotrimoxazole has a better clinical effect on meningitis. To further observe the true effect of the drug, we in February 1978 to April the application of cotrimoxazole in patients with meningitis in 27 cases, the initial step Bu Ming cotrimoxazole treatment of meningitis have a better clinical effect. Now report as follows: First, the choice of case: diagnosis with reference to the 1975 “national prevention and control of meridian exchange of experience seminar discussion draft” diagnostic criteria. All patients diagnosed with meningitis did not use or only used 1 to 2 times a small dose of effective drugs, no effect on the disease who were given cotrimoxazole treatment.